B. Riley raised the firm’s price target on Diversified Healthcare Trust (DHC) to $5.50 from $4.50 and keeps a Buy rating on the shares. The company’s greater capital flexibility post the debt pricing offsets headwinds to 2026 earnings estimates from higher interest expense, the analyst tells investors in a research note. The firm now sees certainty for Diversified’s January repaymet.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DHC:
- Diversified Healthcare Trust Sells Senior Living Management
- Diversified Healthcare Trust reports sale by AlerisLife of 116 management pacts
- Diversified Healthcare Trust’s Optimistic Earnings Call Highlights
- Diversified Healthcare Trust Reports Q2 2025 Results
- Diversified Healthcare Trust (DHC) Q2 Earnings Cheat Sheet